Manila Times Business
Silexion Therapeutics to Attend BIO International Convention 2026
Grand Cayman, June 16, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. ("Silexion” or the "Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that Company management, including the Company’s Chief Executive Officer, Ilan Hadar, and the Company’s Chief Financial Officer, Mirit Horenshtein-Hadar, will attend the 2026 BIO International Convention, taking place on June 22-25 in San Diego, CA. Silexion’s managem
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Bookies.com Updates UK Apple Pay Casinos Guide to Reflect New UKGC Wagering Rules and Bonus Restrictions
2h ago
Falco’s Horne 5 Project: The Government of Québec confirms the project's progress within its environmental authorization process
2h ago
Element Plumbing, Heating, Air & Electrical Named Best Plumber in 2026 Best of Southern Utah Awards
2h ago
SIP, STYLE, TRAVEL, & SUNSHINE: THE SUMMER VIBES TAKING OVER 2026 in Discussion with YourUpdateTV
2h ago